PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12755109

Reconstructing the stem cell debate.

Bradley J Sitko
View original source ↗Export metadata ↓

Abstract

Human embryonic stem cells have been a major topic in science, medicine, and religion since their discovery in 1998. However, due to the complex discourse and rhetoric of scientific language, debate has remained within the professional realm via "expert bioethics." Using the tenets of pragmatism, the author examines the need to move the debate to society as a whole and disentangle the stem cell debate from the ideologies of the human cloning and abortion debates. Opening this issue to a societal debate will advance societal growth, resulting in informed decisions on moral issues, funding, or regulation associated with hES cell research.

Explore related subjects

Advisory CommitteesCommunity ParticipationDecision MakingEmbryo ResearchEmbryo, MammalianHumansMass MediaMoralsPoliticsPublic PolicyStem CellsUnited StatesValue of LifeBiomedical and Behavioral ResearchGenetics and ReproductionNational Bioethics Advisory CommissionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bradley J Sitko. 2002. Reconstructing the stem cell debate.. https://pubmed.ncbi.nlm.nih.gov/12755109/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗